Welcome to the e-CCO Library!

P641: Ustekinumab efficiency as a higher-line therapy in association with serum levels in patients with Crohn’s disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

M. Kolar*1, K. Pudilova1, M. Bortlik1,2,3, D. Duricova1, K. Malickova1,4, M. Lukas1, V. Hruba1, N. Machkova1, R. Vanickova1, K. Mitrova1, M. Vasatko1, M. Lukas1,4

Created: Friday, 22 February 2019, 9:41 AM
P642 Serum adalimumab levels measured between days 9 and 13 from drug injection can be interpreted clinically in a similar way to trough levels in patients with inflammatory bowel disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

J. Guardiola Capón1, K. Serra1, L. Rodríguez-Alonso1, E. Santacana2, N. Padullés2, A. Ruiz-Cerulla1, C. Arajol1, B. Camps1, G. Surís1, E. Sanchez1, F. Rodríguez-Moranta1

Created: Thursday, 30 January 2020, 10:12 AM
P642: Adaptive dosing during infliximab induction therapy can improve mucosal healing rates in patients with ulcerative colitis
Year: 2018
Source: ECCO '18 Vienna
Authors:

E. Dreesen1*, R. Faelens1, G. Van Assche2,3, M. Ferrante2,3, S. Vermeire2,3, A. Gils1, T. Bouillon1

Created: Thursday, 21 February 2019, 9:14 AM
P642: Anxiety and depression: beyond simple consequences of chronic inflammatory bowel diseases
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

O. Timofte*1, E. Gologan1, A. S. Leca2, G-E. Galca-Blanariu1,2, G. Stefanescu1,2

Created: Friday, 22 February 2019, 9:41 AM
P642: Crossroads of vitamin B6 deficiency and inflammation in inflammatory bowel disease: Preliminary results of a cross-sectional study
Year: 2022
Source: ECCO'22
Authors: Farrag, K.(1,2);Woldeab, J.(3);Stein, J.M.(1,2,4);Aksan, A.(2,5);
Created: Friday, 11 February 2022, 3:56 PM
P642: Effects of Covid-19 on employment in IBD patients
Year: 2021
Source: ECCO'21 Virtual
Authors: Sciberras, M.(1);Nascimento, C.(2);Tabone, T.(1);Karmiris, K.(3);Nikolaou, P.(3);Theodoropoulou, A.(3);Mula, A.(1);Goren, I.(4);Yanai, H.(4);Amir, H.(4);Mantzaris, G.(5);Georgiadi, T.(5);Foteinogiannopoulou, K.(6);Koutroubakis, I.(6);Allocca, M.(7);Fiorino, G.(7);Furfaro, F.(7);Katsanos, K.H.(8);Fousekis, F.(8);Michalopoulos, G.(9);Torres, J.(2);Ellul, P.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P642: Impact of histological and endoscopic remission in clinical recurrence and recurrence-free time in ulcerative colitis
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Ponte A., Pinho R., Fernandes S., Rodrigues A., Alberto L., Silva J., Rodrigues J., Sousa M., Leite S., Silva A.P., Proença L., Freitas T., Carvalho J.

Created: Wednesday, 20 February 2019, 10:36 AM
P642: Network meta-analysis: efficacy and safety of treatments for fistulising Crohn's disease
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Chahal, J.(1);Sriranganathan, D.(2);Poo, S.(3);Lo, S.W.(4)*;Kashkooli, S.(4);Garg, M.(4,5);Segal, J.P.(4,5);
Created: Friday, 14 July 2023, 11:12 AM
P643 Development of quantitative ultrasonographic activity score in ileal Crohn’s disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

M. Livne Margolin1, M. Amitai2, E. Klung2, B. Ungar1, R. Eliakim1, S. Ben-Horin1, D. Carter1, U. Kopylov1

Created: Thursday, 30 January 2020, 10:12 AM
P643: Effectiveness of enhanced recovery after surgery in IBD: a propensity score matched cohort study in a single Italian centre
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

M. Mineccia1, M. Daperno*2, P. Massucco1, F. Menonna1, V. Gentile1, P. Germani1, M. Mendolaro2, R. Rocca2, A. Ferrero1

Created: Friday, 22 February 2019, 9:41 AM
P643: Filgotinib decreases systemic and mucosal markers of inflammation that are associated with endoscopic improvement in moderately to severely active Crohn’s disease patients
Year: 2018
Source: ECCO '18 Vienna
Authors:

X. Roblin1*, G. D'Haens2, R. Galien3, L. Goyal4, W. Li4, A. Mirza4, A. Serone4, C. Tasset5, A. Van der Aa5, J. Woo4, S. Vermeire6

Created: Thursday, 21 February 2019, 9:14 AM
P643: Generalizability of Crohn’s disease randomized controlled trials compared to clinical practice
Year: 2022
Source: ECCO'22
Authors: Chhibba, T.(1);Frolkis, A.(2);Ma, C.(2);
Created: Friday, 11 February 2022, 3:56 PM
P643: Patient perspectives and expectations in inflammatory bowel disease: a systematic review
Year: 2021
Source: ECCO'21 Virtual
Authors: Balram, B.(1);Al Khoury, A.(2);Bessissow, T.(3);Afif, W.(3);Gonczi, L.(4);Abreu, M.(2);Lakatos, P.L.(3,4);
Created: Wednesday, 2 June 2021, 4:12 PM
P643: Psoriasis induced by anti-TNF therapy in Inflammatory Bowel Disease: analysis of therapeutic management and evolution of both diseases in a nationwide cohort study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Sanz Segura, P.(1)*;Gomollón, F.(2);García García, S.(3);Vela, M.(4);Fernández-Clotet, A.(5);Muñoz, R.(6);García de la Filia, I.(7);García Prada, M.(8);Ferrer Rosique, J.A.(9);García, M.J.(10);de Francisco, R.(11);Arias, L.(12);Barrio, J.(13);Guerra, I.(14);Ponferrada Diaz, A.(15);P. Gisbert, J.(16);Carrillo-Palau, M.(17);Calvet, X.(18);Márquez-Mosquera, L.(19);Gros, B.(20);Cañete, F.(21);Monfort, D.(22);Madrigal, R.E.(23);Roncero, O.(24);Laredo, V.(2);Montoro, M.(25);Muñoz, C.(26);López-Cauce, B.(27);Lorente, R.(28);Fuentes, A.(29);Vega, P.(30);Martín, D.(31);Nerín de la Puerta, J.(1);Varela, P.(32);Casas-Deza, D.(33);Martínez, P.(34);Pajares, R.(35);J. Lucendo, A.(36);Domènech, E.(21);García-López, S.(33);
Created: Friday, 14 July 2023, 11:12 AM
P643: Therapeutic thresholds for infliximab trough levels during maintenance treatment in patients with inflammatory bowel disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Rasmussen M.*1, Brynskov J.1, Ainsworth M.A.1, Buhl S.1, Bendtzen K.2, Steenholdt C.1

Created: Wednesday, 20 February 2019, 10:36 AM
P644 Post-operative Crohn’s disease recurrence in Glasgow: How common is it and does deprivation matter?
Year: 2020
Source:

ECCO'20 Vienna

Authors:

E. Brownson1, S. Shields1, M.H. Derakhshan1, J. Macdonald1, G. Nicholson2, J.P. Seenan1

Created: Thursday, 30 January 2020, 10:12 AM
P644: Effectiveness of vedolizumab on intestinal outcomes and articular manifestations: Real-world data from the Sicilian Network for inflammatory bowel disease (SN-IBD)
Year: 2018
Source: ECCO '18 Vienna
Authors:

F.S. Macaluso1*, R. Orlando1, W. Fries2, M. Scolaro2, A. Magnano3, D. Pluchino3, M. Cappello4, G.C. Morreale4, S. Siringo5, A.C. Privitera6, C. Ferracane6, N. Belluardo7, N. Alberghina7, M. Ventimiglia1, G. Rizzuto1, S. Renna1, M. Cottone1, A. Orlando1, Sicilian Network for Inflammatory Bowel Disease (SN-IBD)

Created: Thursday, 21 February 2019, 9:14 AM
P644: Factors and salvage surgery for treatment of pouch failure after restorative proctocolectomy for ulcerative colitis – a single-institution study
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Kuroki H., Sugita A., Koganei K., Tatsumi K., Futatsuki R., Obara N.

Created: Wednesday, 20 February 2019, 10:36 AM
P644: Hospitalization and abdominal surgery rates in CD according to drug-dispensing: a temporal trend analysis from the Brazilian public healthcare national system
Year: 2021
Source: ECCO'21 Virtual
Authors: Magro, D.O.(1);Kotze, P.G.(2);Quaresma, A.B.(3);Damiao, A.O.M.C.(4);Valverde, D.A.(5);Panaccione, R.(6);Coward, S.(7);Ng, S.C.(8);Kaplan, G.G.(7);Coy, C.S.R.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P644: Impact of Postoperative Treatment with Immunomodulators and Anti-TNFα agents on long-term Reoperation Rate in ileocaecal Crohn’s Disease.
Year: 2022
Source: ECCO'22
Authors: AratariPhD, A.(1);Scribano, M.L.(2);Baccolini, V.(3);Pugliese, D.(4);De Biasio, F.(1);Verna, S.(2);Morretta, C.(4);Armuzzi, A.(4);Festa, S.(1);Papi, C.(1);
Created: Friday, 11 February 2022, 3:56 PM